EFFECT OF ROUTE OF ADMINISTRATION ON THE CARCINOGENIC ACTION OF DIETHYLNITROSAMINE (N-NITROSODIETHYLAMINE).
D000818:Animals; D001984:Bronchial Neoplasms; D002273:Carcinogens; D006224:Cricetinae; D004052:Diethylnitrosamine; D005260:Female; D006801:Humans; D007267:Injections; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007774:Lactation; D008113:Liver Neoplasms; D009369:Neoplasms; D009374:Neoplasms, Experimental; D009602:Nitrosamines; D009669:Nose Neoplasms; D010336:Pathology; D011247:Pregnancy; D011270:Pregnancy, Animal; D012106:Research; D014116:Toxicology; D014134:Tracheal Neoplasms
D002273:Carcinogens; D009602:Nitrosamines; D004052:Diethylnitrosamine
BRONCHIAL NEOPLASMS; CARCINOGENS; EXPERIMENTAL LAB STUDY; HAMSTERS; INJECTIONS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LACTATION; LIVER NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NITROSAMINES; NOSE NEOPLASMS; PATHOLOGY; PREGNANCY, ANIMAL; TOXICOLOGIC REPORT; TRACHEAL NEOPLASMS